颅内脑膜瘤复发分析中考虑竞争风险的重要性
研究调查2020年以来PubMed收录的脑膜瘤文献中竞争风险分析的使用情况,并基于42家机构约8000例原发脑膜瘤的国际数据库,比较Kaplan-Meier与Aalen-Johansen法估计的复发风险。结果显示仅6%的研究采用Aalen-Johansen分析,多数既往文献高估复发风险,低级别病变和年轻患者中差异可忽略,而高级别病变老年患者中差异显著增大。
要点
- 仅6%的脑膜瘤文献采用Aalen-Johansen竞争风险分析。
- Kaplan-Meier与Aalen-Johansen的差异在低级别病变和年轻患者中可忽略。
- 在竞争事件率高的患者组(老年高级别病变)中差异显著增大。
核心结论
- 脑膜瘤复发风险分析中竞争事件的重要性认识不足,仅6%的调查研究采用Aalen-Johansen分析,多数既往文献高估了复发风险。
- 低级别病变年轻患者中高估可忽略,但高级别病变研究中高估可能显著。
研究设计与样本
- 调查2020年以来PubMed索引的脑膜瘤文献,评估竞争风险分析的使用情况。
- 应用来自42家机构、约8000例原发脑膜瘤患者的国际数据库(PERNS数据库),比较Kaplan-Meier与Aalen-Johansen法的复发风险估计。
- 513篇文章中169篇符合全文筛选条件,PERNS数据库纳入6537例合格病例。
主要发现
- 513篇文章中169篇符合全文筛选,仅6%的研究采用Aalen-Johansen分析。
- Kaplan-Meier与Aalen-Johansen的差异在低级别病变和年轻患者中可忽略。
- 在竞争事件率较高的患者组(老年高级别病变患者)中,两种方法的差异显著增大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of recurrence is overestimated by the Kaplan-Meier method when competing events, such as death without recurrence, are present. Such overestimation can be avoided by using the Aalen-Johansen method, which is a direct extension of Kaplan-Meier that accounts for competing events. Meningiomas commonly occur in older individuals and have slow-growing properties, thereby warranting competing risk analysis. The extent to which competing events are considered in meningioma literature is unknown, and the consequences of using incorrect methodologies in meningioma recurrence risk analysis have not been investigated. METHODS: We surveyed articles indexed on PubMed since 2020 to assess the usage of competing risk analysis in recent meningioma literature. To compare recurrence risk estimates obtained through Kaplan-Meier and Aalen-Johansen methods, we applied our international database comprising ~ 8,000 patients with a primary meningioma collected from 42 institutions. RESULTS: Of 513 articles, 169 were eligible for full-text screening. There were 6,537 eligible cases from our PERNS database. The discrepancy between the results obtained by Kaplan-Meier and Aalen-Johansen was negligible among low-grade lesions and younger individuals. The discrepancy increased substantially in the patient groups associated with higher rates of competing events (older patients with high-grade lesions). CONCLUSION: The importance of considering competing events in recurrence risk analysis is poorly recognized as only 6% of the studies we surveyed employed Aalen-Johansen analyses. Consequently, most of the previous literature has overestimated the risk of recurrence. The overestimation was negligible for studies involving low-grade lesions in younger individuals; however, overestimation might have been substantial for studies on high-grade lesions.
引用
- Mirian C, Jensen LR, Juratli TA, et al. The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol. 2024. PMID: 38336917. doi:10.1007/s11060-024-04572-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。